Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study

Table 1

Demographic and clinical characteristics of participants, mean (±SD).

	Treatment group	Control group
Number of patients	6	12
Age, years	63.5 ± 12.6	70.5 ± 10.3
Gender, male	5 (83%)	10 (85%)
Vintage on dialysis, months	24.3 ± 15.9	30.2 ± 26.4
Arteriovenous fistula as dialysis access, patients	5 (83%)	9 (75%)
Systolic blood pressure, mmHg	140.8 ± 18.7	136.0 ± 19.1
Diastolic blood pressure, mmHg	71.3 ± 16.8	70.2 ± 16.2
Dialysis adequacy (Kt/V, session)	1.33 ± 0.22	1.34 ± 0.15
Haemoglobin, g/dL	11.6 ± 1.6	11.6 ± 1.1
Albumin, g/L	38.7 ± 3.9	40.2 ± 2.9
CRP	13.7 ± 17.1	13.5 ± 15.6
Cause of renal disease, patients
Diabetes mellitus	5 (83%)	7 (58%)
Hypertension	1 (17%)	2 (17%)
ACE inhibitors or ARBs use, patients	3 (50%)	6 (50%)
Furosemide use, patients	4 (67%)	7 (58%)